Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome

Wellington dos Santos(Hospital de Câncer de Barretos), Edilene Santos de Andrade(Hospital de Câncer de Barretos), Felipe Antônio de Oliveira Garcia(Hospital de Câncer de Barretos), Natália Campacci(Hospital de Câncer de Barretos), Cristina da Silva Sábato(Hospital de Câncer de Barretos), Matias Eliseo Melendez(Hospital de Câncer de Barretos), Rui Manuel Reis(Hospital de Câncer de Barretos), Henrique de Campos Reis Galvão(Hospital de Câncer de Barretos), Edenir Inêz Palmero(Hospital de Câncer de Barretos)
Cancers
August 31, 2022
Cited by 16Open Access
Full Text

Abstract

Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome, characterized by germline pathogenic variants in mismatch repair (MMR)-related genes that lead to microsatellite instability. Patients who meet the clinical criteria for LS and MMR deficiency and without any identified germline pathogenic variants are frequently considered to have Lynch-like syndrome (LLS). These patients have a higher risk of CRC and extracolonic tumors, and little is known about their underlying genetic causes. We investigated the germline spectrum of LLS patients through whole-exome sequencing (WES). A total of 20 unrelated patients with MMR deficiency who met the clinical criteria for LS and had no germline variant were subjected to germline WES. Variant classification was performed according to the American College of Medical Genetics and Genomics (ACMG) criteria. Pathogenic/likely pathogenic variants were identified in 35% of patients in known cancer genes such as MUTYH and ATM. Besides this, rare and potentially pathogenic variants were identified in the DNA repair gene POLN and other cancer-related genes such as PPARG, CTC1, DCC and ALPK1. Our study demonstrates the germline mutational status of LLS patients, a population at high risk of colorectal cancer.


Related Papers

No related papers found

Powered by citation graph analysis